CEMEX, S.A.B. de C.V. (CX)

Sage Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	12,178	8,123	11,329	5,853	10,037	7,591
Market Cap Growth	7.12%	-28.30%	93.57%	-41.69%	32.22%	35.99%
Enterprise Value	18,316	15,080	18,840	14,309	18,601	20,088
Last Close Price	8.39	5.60	7.62	3.98	6.67	5.08
PE Ratio	8.09	8.65	62.25	6.82	13.33	-
PS Ratio	0.78	0.50	0.68	0.40	0.70	0.60
PB Ratio	0.89	0.65	0.94	0.54	0.98	0.85
P/TBV Ratio	3.21	2.89	5.07	4.85	156.83	-
P/FCF Ratio	20.87	9.09	8.35	9.55	9.41	7.19
P/OCF Ratio	7.31	4.29	5.10	4.28	5.45	4.76
EV/Sales Ratio	1.17	0.93	1.14	0.97	1.29	1.59
EV/EBITDA Ratio	8.06	5.64	6.68	5.95	6.62	9.43
EV/EBIT Ratio	13.37	8.43	9.84	10.74	11.02	15.88
EV/FCF Ratio	31.38	16.87	13.88	23.34	17.43	19.02
Debt / Equity Ratio	0.51	0.59	0.67	0.81	0.89	1.25
Debt / EBITDA Ratio	2.73	2.51	2.71	3.67	3.27	4.74
Debt / FCF Ratio	11.86	8.23	6.02	14.40	8.61	10.63
Asset Turnover	0.55	0.58	0.60	0.55	0.53	0.45
Inventory Turnover	6.56	6.64	6.41	7.03	8.80	8.84
Quick Ratio	0.57	0.43	0.37	0.42	0.42	0.49
Current Ratio	0.86	0.82	0.74	0.82	0.79	0.79
Return on Equity (ROE)	7.03%	7.42%	1.03%	3.80%	8.50%	-13.61%
Return on Assets (ROA)	3.01%	4.01%	4.36%	3.14%	3.90%	2.78%
Return on Capital (ROIC)	4.26%	5.57%	5.98%	4.25%	5.32%	3.69%
Return on Capital Employed (ROCE)	6.20%	8.40%	8.80%	6.40%	7.90%	5.70%
Earnings Yield	12.37%	11.56%	1.61%	14.66%	7.50%	-19.32%
FCF Yield	4.79%	11.01%	11.98%	10.47%	10.63%	13.91%
Dividend Yield	0.99%	0.16%	0.11%	-	-	-
Payout Ratio	82.31%	24.81%	65.93%	5.94%	3.19%	-
Buyback Yield / Dilution	-0.22%	0.10%	0.54%	1.13%	-1.65%	2.79%
Total Shareholder Return	0.76%	0.26%	0.65%	1.13%	-1.65%	2.79%

Updated Jul 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q